GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Weleader Biomedical Co Ltd (ROCO:7713) » Definitions » Scaled Net Operating Assets

Weleader Biomedical Co (ROCO:7713) Scaled Net Operating Assets : 0.80 (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Weleader Biomedical Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Weleader Biomedical Co's operating assets for the quarter that ended in Jun. 2024 was NT$1,728.2 Mil. Weleader Biomedical Co's operating liabilities for the quarter that ended in Jun. 2024 was NT$342.4 Mil. Weleader Biomedical Co's Total Assets for the quarter that ended in Dec. 2023 was NT$1,727.6 Mil. Therefore, Weleader Biomedical Co's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.80.


Weleader Biomedical Co Scaled Net Operating Assets Historical Data

The historical data trend for Weleader Biomedical Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Weleader Biomedical Co Scaled Net Operating Assets Chart

Weleader Biomedical Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Scaled Net Operating Assets
0.67 0.59 1.40 0.85

Weleader Biomedical Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Scaled Net Operating Assets Get a 7-Day Free Trial - - 0.76 0.86 0.80

Competitive Comparison of Weleader Biomedical Co's Scaled Net Operating Assets

For the Medical Devices subindustry, Weleader Biomedical Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Weleader Biomedical Co's Scaled Net Operating Assets Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Weleader Biomedical Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Weleader Biomedical Co's Scaled Net Operating Assets falls into.



Weleader Biomedical Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Weleader Biomedical Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2023 )
=(Operating Assets (A: Dec. 2023 )-Operating Liabilities (A: Dec. 2023 ))/Total Assets (A: Dec. 2022 )
=(1622.61-255.783)/1600.486
=0.85

where

Operating Assets(A: Dec. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1727.56 - 104.95
=1622.61

Operating Liabilities(A: Dec. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=881.781 - 477.403 - 148.595
=255.783

Weleader Biomedical Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Jun. 2024 )
=(Operating Assets (Q: Jun. 2024 )-Operating Liabilities (Q: Jun. 2024 ))/Total Assets (Q: Dec. 2023 )
=(1728.204-342.364)/1727.56
=0.80

where

Operating Assets(Q: Jun. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1984.417 - 256.213
=1728.204

Operating Liabilities(Q: Jun. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=1148.324 - 648.135 - 157.825
=342.364

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Weleader Biomedical Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Weleader Biomedical Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Weleader Biomedical Co Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 80, Minzu 1st Road, Floor 19, Sanmin District, Kaohsiung, TWN
Weleader Biomedical Co Ltd is mainly engages in the sales of medical testing reagents and medical devices; and the leasing of testing instruments.

Weleader Biomedical Co Headlines

No Headlines